Literature DB >> 8667220

Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status.

D T Lysle1, K E Hoffman, L A Dykstra.   

Abstract

This study was directed at determining whether morphine's immunomodulatory effects are mediated through the periaqueductal gray (PAG). The initial study showed that microinjection of morphine (0.0, 0.4, 4.0, or 40.0 micrograms/rat) into the lateral ventricle induces pronounced dose-dependent reductions in lymphocyte proliferation to T- and B-cell mitogens, natural killer cell cytotoxicity, and the production of interleukin-2 and interferon-gamma. In contrast, microinjection of morphine (0.0, 0.004, 0.04, 0.4, or 4.0 micrograms/rat) into the caudal aspect of the PAG induced dose-dependent alterations in natural killer cell cytotoxicity, but had no effect on lymphocyte proliferation or cytokine production. These results indicate that opioid receptors in the PAG are involved in the regulation of natural killer cell activity, but are not associated with morphine's effects on proliferation or cytokine production. A subsequent study showed that the effect of morphine in the PAG is restricted to the more caudal aspects of the PAG because microinjections of morphine into the rostral aspects do not result in any alteration of immune status. To determine that the activation of opioid receptors in the PAG is not only sufficient, but is required for morphine's effects on natural killer cell activity, N-methylnaltrexone was administered into the PAG (0, 0.0001, 0.001, or 0.01 micrograms/rat) before the systemic administration of morphine (15 mg/kg), a dose that induces pronounced alterations of natural killer cell activity. The results showed that the administration of N-methylnaltrexone directly into the PAG antagonized morphine's effects on natural killer cell activity, which indicate that activation of opioid receptors within the PAG are required for morphine to alter natural killer cell activity. Collectively, this study showed that activation of opioid receptors within the more caudal aspects of the PAG are required for morphine to induce alterations in splenic natural killer cell activity. The results also suggest that other brain regions are responsible for morphine's effect on lymphocyte proliferation and cytokine production.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8667220

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

Review 1.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

2.  Fos expression in the rat brain after intraperitoneal injection of Staphylococcus enterotoxin B and the effect of vagotomy.

Authors:  Xi Wang; Bai-Ren Wang; Xi-Jing Zhang; Xiao-Li Duan; Xiang Guo; Gong Ju
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

Review 3.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

4.  Ventral tegmental area-basolateral amygdala-nucleus accumbens shell neurocircuitry controls the expression of heroin-conditioned immunomodulation.

Authors:  Jennifer L Szczytkowski; Rita A Fuchs; Donald T Lysle
Journal:  J Neuroimmunol       Date:  2011-07-01       Impact factor: 3.478

Review 5.  Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.

Authors:  Sabita Roy; Jana Ninkovic; Santanu Banerjee; Richard Gene Charboneau; Subhas Das; Raini Dutta; Varvara A Kirchner; Lisa Koodie; Jing Ma; Jingjing Meng; Roderick A Barke
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-26       Impact factor: 4.147

6.  Morphine-6beta-glucuronide modulates the expression of inducible nitric oxide synthase.

Authors:  D T Lysle; K A Carrigan
Journal:  Inflammation       Date:  2001-08       Impact factor: 4.092

7.  Region-specific contribution of the ventral tegmental area to heroin-induced conditioned immunomodulation.

Authors:  Lee W Hutson; Jennifer L Szczytkowski; Timothy B Saurer; Christina Lebonville; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2014-01-24       Impact factor: 7.217

8.  Heroin-induced conditioned immunomodulation requires expression of IL-1β in the dorsal hippocampus.

Authors:  Jennifer L Szczytkowski; Christina Lebonville; Lee Hutson; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2013-01-26       Impact factor: 7.217

9.  Evidence for the nucleus accumbens as a neural substrate of heroin-induced immune alterations.

Authors:  Timothy B Saurer; Stephanie G Ijames; Donald T Lysle
Journal:  J Pharmacol Exp Ther       Date:  2009-03-03       Impact factor: 4.030

10.  Acquisition of heroin conditioned immunosuppression requires IL-1 signaling in the dorsal hippocampus.

Authors:  Christina L Lebonville; Meghan E Jones; Lee W Hutson; Letty B Cooper; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2016-04-09       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.